Cheng-Ta Li
Professor and Chief of the Division of Community and Rehabilitation Psychiatry
Data updated
Research Footprint
Cheng-Ta Li appears in 4 tracked papers (2016–2023), most studied alongside Ketamine and Placebo, across Depressive Disorders, Treatment-Resistant Depression (TRD) and Suicidality.
Most-cited paper: Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression (205 citations).
Frequent co-authors: Tung-Ping Su, Mu-Hong Chen and Wei-Chen Lin.
Background & Research
Cheng-Ta Li, MD, PhD, is a psychiatrist at Taipei Veterans General Hospital and a faculty member at National Yang Ming Chiao Tung University. His research focuses on treatment-resistant depression, suicidal ideation, ketamine treatment, and neuroimaging markers of antidepressant response. He is listed as Chief of the Division of Community and Rehabilitation Psychiatry at Taipei Veterans General Hospital.
Key Impact
He is a senior psychiatrist and researcher in Taiwan with multiple influential studies on treatment-resistant depression and ketamine.
Collaboration Network
4 collaborators· click a node to visit their profile
Full network →